Microsomal triglyceride transfer protein inhibitor (lomitapide) efficacy in the treatment of patients with homozygous familial hypercholesterolaemia

Genovefa Kolovou,Olga Diakoumakou,Vana Kolovou,Epameinondas Fountas,Stavros Stratakis,Evangelos A. Zacharis,Evangelos N. Liberopoulos,Fedra Matsouka,Alexandros Tsoutsinos,Irene Mastorakou,Theodoros Katsikas,Sophie Mavrogeni,Georgios Hatzigeorgiou

Microsomal triglyceride transfer protein inhibitor (lomitapide) efficacy in the treatment of patients with homozygous familial hypercholesterolaemia

2019

Genovefa Kolovou
Olga Diakoumakou
Vana Kolovou
Epameinondas Fountas
Stavros Stratakis
Evangelos A. Zacharis
Evangelos N. Liberopoulos
Fedra Matsouka
Alexandros Tsoutsinos
Irene Mastorakou
Theodoros Katsikas
Sophie Mavrogeni
Georgios Hatzigeorgiou

AimsThe aim of this study was to evaluate the effect of microsomal triglyceride transfer protein inhibitor (lomitapide) in patients with homozygous familial hypercholesterolaemia.Methods and result...

Keywords:

Medicine
Microsomal triglyceride transfer protein
Diabetes mellitus
Internal medicine
Physical therapy
Lomitapide
Endocrinology
Low density lipoprotein apheresis
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations